Sunday, December 22nd, 2024

H2G Green Announces Renounceable Rights Issue of 1.4 Billion Warrants to Raise Up to S$7 Million






H2G Green Limited Announces Exciting Renounceable Rights Issue


H2G Green Limited Announces Exciting Renounceable Rights Issue

Key Points:

  • H2G Green Limited is proposing a renounceable non-underwritten rights issue of up to 1,415,284,092 warrants at an issue price of S\$0.001 per warrant.
  • Each warrant allows shareholders to purchase one new ordinary share at an exercise price of S\$0.004.
  • The exercise price represents a significant discount of approximately 63.64% to the last traded price of S\$0.011 per share on 4 September 2024.
  • The warrants issue is subject to shareholder approval at an extraordinary general meeting (EGM).
  • RHT Capital Pte. Ltd. has been appointed as the issue manager.

Important Shareholder Information:

  • Shareholders will be provisionally allotted one warrant for every existing share held as of the record date, which is yet to be determined.
  • The proceeds from the warrants issue will be used for general working capital purposes and to strengthen the financial position of the company.
  • Shareholders have the liberty to accept, decline, renounce, or trade their provisional allotments during the trading period prescribed by the SGX-ST.
  • There will be an opportunity for shareholders to apply for excess warrants beyond their provisional allotments.
  • Foreign shareholders with registered addresses outside Singapore will not be offered the warrants.
  • Key shareholders, including Mr. Lim Shao-Lin and Gashubunited Holding Private Limited, have indicated their intent to subscribe for their direct entitlements, demonstrating strong commitment to the company.

Details of the Warrants Issue:

  • The exercise period for the warrants is 36 months from the date of issue.
  • Any unexercised warrants will lapse and cease to be valid at the end of the exercise period.
  • The warrants and the new shares arising from their exercise will be listed and traded separately on the Catalist.
  • The new shares will rank pari passu with the existing shares for dividends, rights, allotments, or other distributions.
  • The company has not undertaken any equity fund-raising exercise in the last 12 months.

The Board believes that the warrants issue will allow existing shareholders to participate in the future growth of the group, strengthen the financial position and capital base, and provide additional cash resources for new opportunities and business growth. The increased number of shares in issue could also potentially enhance trading liquidity.

Disclaimer: The proposed warrants issue is subject to certain conditions being fulfilled and there is no certainty or assurance that the warrants issue will be completed or that no changes will be made to the terms. Shareholders are advised to exercise caution and consult their professional advisers before making any decisions. Further announcements will be made by the company as appropriate.

By Order of the Board,
Lim Shao-Lin
Executive Director, CEO
4 September 2024


Centurion Corporation’s Q3 2024 Business Update: Strong Growth in PBWA and PBSA Markets, Expansion into Build-to-Rent Segment

Centurion Corporation: Strategic Expansion and Strong Performance in 3Q 2024 Centurion Corporation: Strategic Expansion and Strong Performance in 3Q 2024 Centurion Corporation Limited has reported a remarkable performance in its 3Q 2024 business update,...

Clearbridge Health Receives SGX-ST Approval for Massive 1.28 Billion Rights Share Issuance

Clearbridge Health’s Strategic Share Issue: A Potential Game Changer for Investors Clearbridge Health’s Strategic Share Issue: A Potential Game Changer for Investors Clearbridge Health Limited, a prominent player in Singapore’s healthcare sector, has announced...

IREIT Global Q3 2024 Update: Portfolio Resilience, Berlin Campus Transformation, and Western European Real Estate Outlook

IREIT Global Shows Resilient Performance Amidst European Market Shifts IREIT Global Shows Resilient Performance Amidst European Market Shifts In its 3Q2024 business update, IREIT Global has demonstrated a stable performance and strategic foresight in...